NHI Natunola Health Biosciences In

Advitech Inc. ("Advitech" or the "Corporation") (TSX VENTURE:AVI) and Natunola
Health Biosciences Inc. ("Natunola") (TSX VENTURE:NHI) announce changes to the
terms of the previously announced proposed private placement, which is a
condition precedent to the completion of their proposed merger transaction (the
"Transaction") under the terms of the merger agreement entered into between
Advitech and Natunola on June 29, 2011. 


Under the new terms of the proposed private placement, Advitech intends to issue
a minimum of 116,666,667 units (the "Units") at a price of $0.03 per Unit for
minimum gross proceeds of $3,500,000. The previously announced price per Unit
was $0.04. Each Unit is being comprised of one common share and one half of one
common share purchase warrant of Advitech. Each whole common share purchase
warrant will entitle its holder to acquire one additional common share of
Advitech at a price of $0.04 ($0.16 post Consolidation (as defined hereinafter))
for a period of 36 months following closing. The previously announced exercise
price per whole warrant was $0.05. Avrio Ventures Limited Partnership and
AgeChem Venture Fund L.P., which are shareholders of Advitech holding more than
10% of its issued and outstanding shares, have indicated they will be
participating in the private placement and that they may acquire, in the
aggregate, 25% or more of the units issued as part of the private placement.


As announced on August 4, 2011, during a special shareholders' meeting held on
August 3, 2011, the shareholders of Natunola approved the resolutions
authorizing the continuation of the corporation from the Business Corporations
Act (Alberta) to the Canada Business Corporations Act and the resolutions
authorizing the amalgamation of Natunola with 7894716 Canada Inc., a wholly
owned subsidiary of Advitech (the "Amalgamation"). During a special
shareholders' meeting of Advitech held on the same day, the Advitech
shareholders conditionally approved the election of Dr. Nam Fong Han and David
Edwards to the board of directors of Advitech, as well as other ancillary
resolutions to the Amalgamation, namely the proposed change of name of Advitech
Inc. to "Botaneco Corp." following the closing of the amalgamation, as well as
the consolidation of all outstanding common shares of Advitech on a 4:1 basis,
immediately following the closing of the Amalgamation (the "Consolidation"). The
parties are working towards fulfilling conditions to the Transaction and expect
to complete the Transaction before the end of September. The Natunola
shareholders will continue to receive common shares of Advitech based on a ratio
of 4.75 common shares of Advitech (or 1.1875 common shares following a proposed
4 to 1 consolidation of Advitech shares) for each common share of Natunola.


Bloom Burton & Co. (the "Agent") has been jointly retained by Advitech and
Natunola as agent for the purposes of the private placement of Advitech. The
Agent will be entitled to receive, upon completion of the Transaction in
consideration for the services rendered as part of the private placement, a cash
fee equal to up to 7% of gross proceeds raised in connection with the private
placement and that number of agents' warrants equal to up to 7% of the number of
common shares issued as part of the private placement. Such warrants will
entitle their holders to acquire Units at a price of $0.03 per Unit ($0.12 post
Consolidation) for a period of 24 months following closing. The Agents will also
receive a work fee of $100,000, payable in cash or in shares, at the option of
Advitech, within 10 days of the closing of the Transaction. 


About Advitech Inc.:

Advitech, which includes its subsidiary Botaneco Specialty Ingredients Inc.
since November 20, 2009, is a health sciences and technology company developing,
manufacturing and marketing proprietary natural ingredients and formulations for
oral and topical applications that have been clinically proven to be safe and
effective for improving skin health and well being. More information is
available and can be accessed at www.advitech.com 


About Natunola Health Biosciences Inc.:

Natunola and its manufacturing plant are located in Winchester, Ontario.
Natunola is a manufacturer and researcher in the field of flax seed derived
omega -3 fatty acids, flax protein, flax lignans, specialty natural products,
bio-nutrients and functional supplements for human and animal care markets.
Natunola also produces canola oil gels and other natural ingredients for the
cosmetic and personal care industry. Natunola has a retail health product line
under the brand name of Natunola(R) Health's Delight. Natunola was the winner
for the National Canadian Agri-Food Award of Excellence for Innovation for the
year 2008. www.natunola.com


Cautionary Statements:

This news release contains forward-looking statements and information ("forward
looking statements") within the meaning of applicable securities laws relating
to the proposal to complete the proposed plan of arrangement and associated
transactions (including the private placement financing), including statements
regarding the terms and conditions of the proposed plan of arrangement and
associated transaction. Readers are cautioned to not place undue reliance on
forward-looking statements. Actual results and developments may differ
materially from those contemplated by these statements depending on, among other
things, the risks that the parties will not proceed with the proposed plan of
arrangement and associated transactions, that the ultimate terms of the proposed
plan of arrangement and associated transactions will differ from those that
currently are contemplated, and that the proposed plan of arrangement and
associated transactions will not be successfully completed for any reason
(including the failure to obtain the required approvals or clearances from
regulatory authorities or to complete the concurrent financing). Furthermore,
the forward-looking statements contained in this document are made as of the
date of this document and, except as required by applicable law and neither
Advitech nor Natunola does not undertakes any obligation to publicly update or
to revise any of the included forward-looking statements, whether as a result of
new information, future events or otherwise. The forward-looking statements
contained in this document are expressly qualified by this cautionary statement.

Natunola Health Biosciences In (TSXV:NHI)
Historical Stock Chart
From May 2024 to Jun 2024

Natunola Health Biosciences In (TSXV:NHI)
Historical Stock Chart
From Jun 2023 to Jun 2024